Multiple sclerosis and Melasma

Summary:

Melasma is found among people with Multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Melasma with Multiple sclerosis. It is created by eHealthMe based on reports of 18 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,089 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Melasma?

Melasma (the mask of pregnancy when present in pregnant women) is a tan or dark skin discoloration) is found to be associated with 37 drugs and 236 conditions by eHealthMe. Check the latest studies of Melasma.



On Jul, 12, 2026

18 people who have Multiple Sclerosis and Melasma are studied.

Would you have Melasma when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Melasma *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Multiple Sclerosis and experienced Melasma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.76 %
  • 30-39: 0.0 %
  • 40-49: 64.71 %
  • 50-59: 17.65 %
  • 60+: 5.88 %

Common co-existing conditions for these people *:

  1. Insomnia (sleeplessness): 2 people, 11.11%
  2. Depression: 2 people, 11.11%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.56%

Common drugs taken by these people *:

  1. Gilenya: 12 people, 66.67%
  2. Tysabri: 5 people, 27.78%
  3. Sertraline: 3 people, 16.67%
  4. Aubagio: 2 people, 11.11%
  5. Cymbalta: 2 people, 11.11%
  6. Zolpidem: 1 person, 5.56%
  7. Ampyra: 1 person, 5.56%
  8. Avonex: 1 person, 5.56%
  9. Betaseron: 1 person, 5.56%
  10. Escitalopram: 1 person, 5.56%

Common symptoms for these people *:

  1. Hair Loss: 7 people, 38.89%
  2. Lymphocyte Count Decreased: 6 people, 33.33%
  3. Depression: 5 people, 27.78%
  4. Fatigue (feeling of tiredness): 4 people, 22.22%
  5. Lymphopenia (an abnormally low level of lymphocytes in the blood): 4 people, 22.22%
  6. Balance Disorder: 4 people, 22.22%
  7. Essential Hypertension (primary hypertension): 3 people, 16.67%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  9. Concomitant Disease Aggravated (advanced due to some of accompanying): 3 people, 16.67%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Melasma?

- Check whether Melasma is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Melasma:

All the conditions that are associated with Melasma:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Melasma and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: